Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.80 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.80 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.56 |
| ▸ | NOD1 | Q9Y239 | 10/20 | 0.47 |
| ▸ | FNTA | P49354 | 2/20 | 0.43 |
| ▸ | FNTB | P49356 | 2/20 | 0.43 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13160954 | 1.00 | PTGS1 (0.80) | PTGS1GSTK1GLO1NOD1FNTA | |
| Glutathione SCHEMBL20298530 | 0.91 | PTGS1 (0.92) | PTGS1GSTK1GLO1NOD1FNTA | |
| Glutathione SCHEMBL8215210 | 0.91 | PTGS1 (0.92) | PTGS1GSTK1GLO1NOD1FNTA | |
| Glutathione SCHEMBL8215201 | 0.91 | PTGS1 (0.92) | PTGS1GSTK1GLO1NOD1FNTA | |
| Glutathione SCHEMBL20298529 | 0.91 | PTGS1 (0.92) | PTGS1GSTK1GLO1NOD1FNTA | |
| Glutathione SCHEMBL28212822 | 0.90 | PTGS1 (0.90) | PTGS1GSTK1GLO1NOD1FNTA | |
| Glutathione SCHEMBL3790499 | 0.89 | PTGS1 (0.95) | PTGS1GSTK1GLO1NOD1FNTA | |
| Glutathione SCHEMBL3790504 | 0.89 | PTGS1 (0.95) | PTGS1GSTK1GLO1NOD1FNTA | |
| Glutathione SCHEMBL1105665 | 0.89 | PTGS1 (1.00) | PTGS1GSTK1GLO1NOD1FNTA | |
| Glutathione SCHEMBL14364095 | 0.89 | PTGS1 (1.00) | PTGS1GSTK1GLO1NOD1FNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230144527-A1 | STABLE ASCORBIC ACID COMPOSITIONS AND METHODS OF USING SAME | RENOVION, INC. | 2023-05-11 | — | — | US | disclosed |
| US-9963621-B2 | Manufacturing method of quantum dot glue, quantum dot glue and quantum dot polarizer | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2018-05-08 | — | — | US | disclosed |
| US-20180100090-A1 | MANUFACTURING METHOD OF QUANTUM DOT GLUE, QUANTUM DOT GLUE AND QUANTUM DOT POLARIZER | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2018-04-12 | — | — | US | disclosed |
| US-8067380-B2 | Glutathione-based delivery system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2011-11-29 | — | — | US | disclosed |
| US-7704956-B2 | Glutathione-based delivery system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-04-27 | — | — | US | disclosed |
| US-7700564-B2 | Glutathione based delivery system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-04-20 | — | — | US | disclosed |
| US-20090123531-A1 | GLUTATHIONE-BASED DELIVERY SYSTEM | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2009-05-14 | — | — | US | disclosed |
| US-20090060991-A1 | GLUTATHIONE BASED DELIVERY SYSTEM | WANG AE-JUNE | 2009-03-05 | — | — | US | disclosed |
| US-7446096-B2 | Glutathione based delivery system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2008-11-04 | — | — | US | disclosed |
| US-20080095836-A1 | Glutathione-based delivery system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE | 2008-04-24 | — | — | US | disclosed |
| US-20070141133-A1 | Liposomes; analgesics; glutathione is covalently bound to polyethylene glycol,wherein the polyethylene glycol is covalently bound to vitamin E or a phospholipid | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070141133-A1 | Liposomes; analgesics; glutathione is covalently bound to polyethylene glycol,wherein the polyethylene glycol is covalently bound to vitamin E or a phospholipid | GSTO1, GSTP1, GSTA1 | PTGS1 17/4885GSTK1 7/4885GLO1 82/4885 |
| US-20080095836-A1 | Glutathione-based delivery system | GSTP1, GSS, GSTA1 | PTGS1 17/4885GSTK1 7/4885GLO1 23/4885 |
| US-20090060991-A1 | GLUTATHIONE BASED DELIVERY SYSTEM | GPX4, GSTO1, GPX1 | PTGS1 30/4885GSTK1 8/4885GLO1 37/4885 |
| US-20090123531-A1 | GLUTATHIONE-BASED DELIVERY SYSTEM | GSTO1, GPX4, GPX1 | PTGS1 29/4885GSTK1 8/4885GLO1 38/4885 |
| US-20230144527-A1 | STABLE ASCORBIC ACID COMPOSITIONS AND METHODS OF USING SAME | GPX1, GSTA1, GPX4 | PTGS1 689/4885GSTK1 11/4885GLO1 29/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.